Previous 10 | Next 10 |
Mir Basar Suhaib/iStock via Getty Images Recently IPO’ed biotech firms Prometheus Biosciences ([[RXDX]] -21.5%) and Recursion Pharmaceuticals ([[RXRX]] -19.2%) are on course to record their biggest one-day losses since their public debut in March and April, respectively. As demons...
Recursion (RXRX) announces the formation of a Therapeutics Advisory Board ((TAB)), chaired by Joseph Miletich.Most recently, Miletich was Merck Research Laboratories' senior vice president of research sciences and is currently senior scientific advisor to Merck's CEO.Prior...
Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD Therapeutics Advisory Board to help guide Recursion's growing clinical pipeline through development PR Newswire SALT LAKE CITY , July 13, 2021 /PRNewswire/ -- Recursion (...
Recursion Opens Child Care Center to Support Employees Recursion and Bright Horizons partner to open child care center in Gateway Mall, next to Recursion's Salt Lake City headquarters PR Newswire SALT LAKE CITY , July 12, 2021 /PRNewswire/ -- Recursion (NASDA...
Recursion Signs Lease With Vestar for an Additional 100,000 sf of Space at the Gateway in Downtown Salt Lake City PR Newswire SALT LAKE CITY , July 1, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by i...
Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery Canada NewsWire Recursion to open office space within Mila and build machine learning team to focus on some of drug discovery's most challenging problems MONTRÉAL, June 23, ...
Recursion Announces its First Major Multidisciplinary Expansion, in Toronto, to Further Tech-Enabled Drug Discovery Canada NewsWire The company aims to hire up to 50 people by the end of 2021 across disciplines of data science, machine learning, engineering, product mana...
Recursion Announces First Internally-Developed NCE Advanced to IND-Enabling Studies to Potentially Treat Clostridium difficile Colitis PR Newswire SALT LAKE CITY , May 25, 2021 /PRNewswire/ -- Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage...
Shares of Recursion Pharmaceuticals (RXRX) have shot up 10.4% in afternoon trading following a disclosure that Cathie Wood's ARK Genomic Revolution ETF (ARKG) added to its position in the biotech.The fund bought 14,440 shares yesterday, with Recursion now accounting for a 0.0039% st...
"If you own the turbo-charged growth stocks... you either need to steel yourself for the pain or cut your losses on the next sharp move up, because we're in a new market that’s very different from last year," Jim Cramer said in the latest episode of Mad Money. "What worked in 2020 hasn...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
2024-07-27 05:41:00 ET Investors looking for stocks that can make dramatic gains often turn toward the biotechnology sector. It isn't unusual for stocks in this industry to shoot higher in response to positive clinical-trial results for experimental new drugs. Recursion Pharmaceutical...
2024-07-13 09:29:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) is arguably one of the most unique drugmakers on the planet. Though it's classified as a biotech company, its claim to fame is an artificial intelligence (AI)-based approach to speeding up drug discovery and development...
2024-07-11 10:10:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmac...